학술논문

A phase 2 trial investigating the efficacy and safety of the mPGES-1 inhibitor vipoglanstat in systemic sclerosis-related Raynaud's
Document Type
Artikel
Source
Rheumatology (Oxford, England).
Subject
Medicin och hälsovetenskap
Language
English
English
ISSN
1462-0332